We are monitoring the impact of COVID-19 on Infectious Diseases Diagnostics Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 4449
Share on
Share on

Global Infectious Diseases Diagnostics Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report – Segmented By Product, Application, Technology, Traditional methods, End User & Region - Industry Forecast (2021 to 2026)

Pulished: April, 2021
ID: 4449
Pages: 170

Global Infectious Disease Diagnostics Market Size (2021 To 2026)

The Infectious disease diagnostics market size at a global level is anticipated to grow at a 7.9% CAGR from 2021 to 2026. It is estimated that the global market was valued at USD 18.15 billion in 2021 and is relied upon to achieve USD 26.54 billion by 2026.

Infectious disease diagnostics involves various methods to check for foreign antigen/organism presence with the help of numerous diagnostic tools. Infectious disease conditions are prevalent in underdeveloped regions owing to the lack of awareness for personal hygiene, minimal health care expenditures, and the absence of efficient physician services.

MARKET DRIVERS:

Rising cases of infectious diseases in developed economies are further expected to boost the global infectious disease diagnostics market growth.

It has lead vitro diagnostic device manufacturers to invest in emerging economies. These companies are making efforts to develop and commercialize cost-effective tools for infectious disease diagnosis. Disease diagnostics are used to confirm the disease in the form of a quick, precise test result. Being time-consuming, disease diagnostics are on the rise. In addition, infectious disease epidemics are spreading worldwide, leading to increased demand for diagnostic tests. The incidences of malaria, flu, AIDS and other diseases are again rising, creating a robust demand for infectious disease diagnostics.

With most physicians adopting the evidence-based treatment method, infectious disease diagnostic kits are more likely to gain traction over the forecast period.

Several government-funded programs worldwide are increasingly providing free screening and tests to increase awareness, accurately diagnose diseases, and minimize the chances of infection. Such initiatives are anticipated to boost market growth in the next few years.

The rise in the prevalence of infectious diseases such as HIV, hepatitis, and others create lucrative growth opportunities for key market players in the global infectious disease diagnostics market. Furthermore, increasing demand for point-of-care testing systems is anticipated to offer many growth opportunities for the stakeholders operating in the infectious disease diagnostics market during the forecast period. In addition, increasing economies of developed and developing nations such as the U.S., Brazil, Canada, India, China led to the expansion of healthcare, providing several opportunities to the key players in the infectious disease diagnostics market.

The increasing need to develop novel and useful diagnostic techniques due to the consistently rising population diagnosed with contagious diseases is supposed to provide lucrative opportunities for the growth of the infectious disease diagnostics market during the forecast period. Furthermore, the emergence of faster and reliable diagnostic techniques and the equipment integrated with artificial intelligence and machine learning offers growth opportunities for the global infectious disease diagnostics market.

MARKET RESTRAINTS:

However, diagnostic kits are expensive, and manufacturers still have an inadequate distribution channel for operating across emerging economies. These two factors are projected to be the key challenges to the rapid growth of the global infectious disease diagnostics market.

Impact of COVID-19 on the global infectious disease diagnostics market:

The COVID 19 is a pandemic declared by the World Health Organization (WHO). The new coronavirus was added to the list in January 2020 as the 40th disease condition. With the widespread COVID-19 pandemics, countries worldwide are struggling to diagnose and control the disease. The first mobile I-Lab was launched in India by the Union Minister of Health and Family Welfare for COVID 19 testing. The I-Lab can be used in the remote, interior, and inaccessible parts of the country. In response to the increasing number of COVID-19 cases, a Brazilian multinational corporation has purchased 5 million new COVID-19 rapid test kits to help the Brazilian government. The outburst of the new virus is affecting the vast population and is spreading continuously in the region. Many of the committed healthcare professionals are working tirelessly on the frontline to battle critical conditions. The COVID-19 pandemic has increased the need for diagnostic kits, leading to increased IDD market demand. Therefore, the COVID-19 has favored the IDD market and is expected to accelerate the market's growth rate during the forecast period.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2020 to 2026

Base Year

2020

Forecast Period

2021 to 2026

Segments Analysed

By Product, Application, Technology, Traditional methods, End User & Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Analysed

North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Companies Analysed

Abbott Laboratories, bioMérieux SA, Hologic, Inc., Danaher Corporation, Becton, Dickinson and Company, Cepheid, Inc., Thermo Fisher Scientific Inc., Roche Diagnostics, Alere Inc., DiaSorin S.p.A., Quidel Corporation, and Bio-Rad Laboratories, Inc.

 

This research report on the global infectious disease diagnostics market has been segmented and sub-segmented into the following categories.

Infectious disease diagnostics market - By Product:

  • Instruments
  • Reagents
  • Services
  • Software

Infectious disease diagnostics market - By Application:

  • Hepatitis B
  • Hepatitis C
  • Human Immunodeficiency Virus (HIV)
  • Tuberculosis (TB)
  • Chlamydia trachomatis
  • Neisseria gonorrhoeae (CT/NG)
  • Human papillomavirus (HPV)
  • Methicillin-resistant Staphylococcus aureus (MRSA)
  • and others (Influenza, Ebola, Typhoid, Malaria, and Dengue)

Based on application, the Hepatitis B segment is the most lucrative and forecasted to register healthy CAGR during the forecast period due to the high prevalence of the disease and increased adoption of advanced diagnostics methods for Hepatitis B. HIV, tuberculosis, and influenza is overgrowing at a high pace. Therefore, it is expected to contribute a significant share to the global infectious diagnostics market during the forecast period.

Infectious disease diagnostics market - By Technology:

  • PCR
  • INAAT
  • DNA Sequencing
  • Hybridization

Based on technology, the DNA Sequencing segment is estimated to account for the most significant share in the global market during the forecast period. Furthermore, it is likely to display growth at a high CAGR during the forecast period due to cost reduction and technological improvements of next-generation sequencing.

 Infectious disease diagnostics market - By Traditional methods:

  • Immunodiagnostics
  • Microscopy
  • Biochemical Characterization

Infectious disease diagnostics market - By End User:

  • Hospital
  • Laboratories

Based on end-user, the hospital segment leads the market due to the factors such as reimbursements offered by the governments, accessibility to the patients, availability of advanced diagnostics equipment in the hospitals, and high flow of patients in hospitals. On the other hand, the laboratory segment is contributing a significant share to the market. It is likely to continue the trend during the forecast period owing to the increasing adoption of automated diagnostics technologies in laboratories such as mass spectrometry and PCR. 

Infectious disease diagnostics market - By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

Geographically, the North American market held the largest share of the IDD market, followed by Europe in 2020. Both regions are projected to witness single-digit growth rates during the coming years. The North American market growth is due to the growing occurrence of contagious diseases and the easy availability of technology instruments. The United States secures the highest demand in the region. In 2014, a total of more than 110,000 deaths occurred due to infectious diseases. Increased incidence of dreadful ailments and rising demand to develop new drugs are propelling the market's growth rate. For instance, 30 million people in the U.S. alone suffer 7,000 varieties of rare diseases. The Canadian infectious diseases diagnostics market is the fastest growing in North America due to the high awareness levels of practitioners and patients and sophisticated healthcare infrastructure uplift the market growth.

The European infectious diseases diagnostics market was the second-largest market globally in 2020 and predicted to showcase a healthy CAGR during the forecast period. The high adoption of premium diagnostic techniques maintains the market share in the region. Germany leads the infectious diseases diagnostics market in the area. The quick increase in the chronic and contagious disease population and advanced technologies escalate market growth. As per the German Diagnostics Industry Association (VDGH), the IVD and reagent market turnover recorded in 2017 amounted to approximately EUR 2-3 billion. The U.K market witnessed to have rapid growth during the analysis period. The government's measures to develop suitable healthcare infrastructure among the existing economies are propelling the market demand. The Centre for Excellence in Infectious Diseases Research in Liverpool is engaging with companies to promote diagnostics over the areas of malaria, TB, HIV, NTDs, and Sepsis.

Be that as it may, Asia-Pacific is projected to register the highest growth rate in the coming years due to the increased pervasiveness of infectious diseases and tremendous investment opportunities due to a growth in healthcare expenditure. The infectious disease diagnostics market in the Asia-Pacific region is to register a quick growth rate during the estimated period. The increasing frequency of contagious diseases and enormous investment opportunities because of the rising healthcare expenditure. The growing requirement for developing new and useful diagnostics is an increased population diagnosed with infectious diseases. China is leading the IDD market with impressive market growth. The Chinese government's latest initiative is to mandate that all the blood be tested using nucleic acid technologies by the end of 2015. The acquisition of advanced molecular procedures, primarily sexually transmitted diseases such as HIV and bacterial infections, accelerates the market growth. Countries like Japan and India have impressive market growth in the Infectious diseases diagnostics market during the period.

KEY MARKET PARTICIPANTS:

Some of the prominent companies dominating the global infectious disease diagnostics market profiled in the report are Abbott Laboratories, bioMérieux SA, Hologic, Inc., Danaher Corporation, Becton, Dickinson, and Company, Cepheid, Inc.m, Thermo Fisher Scientific Inc., Roche Diagnostics, Alere Inc., DiaSorin S.p.A., Quidel Corporation and Bio-Rad Laboratories, Inc.

RECENT HAPPENINGS IN THIS MARKET:

  • In 2019, Abbott laboratories launched a novel product called Alinity m diagnostic system. The product is applied to enhance the molecular diagnostic testing by reducing the span and number of instruments needed for the trial; owing to this, a large number of tests can be conducted in shorter timeframes.
  • A research team from the National University of Singapore has developed an effective technology called envision for detecting diseases significantly less time frame. Envision has the potential to identify the disease and its subtypes at low costs and faster rates. In addition, the tests' results are easily accessible to patients and can be analyzed by smartphones, an outstanding feature that makes reliable device telemedicine.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Product                        

                                5.1.1 Introduction           

                                5.1.2  Instruments & Analyzers 

                                5.1.3 Consumables         

                                                5.1.3.1 Assays and Reagents

                                5.1.4 Services & Softwares          

                                5.1.5  Y-o-Y Growth Analysis, By Product              

                                5.1.6  Market Attractiveness Analysis, By Product            

                                5.1.7  Market Share Analysis, By Product              

                5.2 Technique                   

                                5.2.1 Introduction           

                                5.2.2 Traditional Diagnostic Techniques 

                                                5.2.2.1 Immunodiagnostics

                                                5.2.2.2  Microscopy

                                                5.2.2.3 Biochemical Characterization

                                5.2.3 Molecular Diagnostics        

                                                5.2.3.1 PCR

                                                5.2.3.2 INAAT

                                                5.2.3.2 Hybridization

                                                5.2.3.3 DNA Sequencing & NGS 

                                                5.2.3.4 Microarray

                                                5.2.3.5 Others

                                5.2.4 Y-o-Y Growth Analysis, By Technique          

                                5.2.5 Market Attractiveness Analysis, By Technique        

                                5.2.6 Market Share Analysis, By Technique          

                5.3 Application                 

                                5.3.1 Introduction           

                                5.3.2 Hepatitis B               

                                5.3.3 Hepatitis C               

                                5.3.4 Human Immunodeficiency Virus (HIV)        

                                5.3.5 Tuberculosis (TB)  

                                5.3.6 Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG)            

                                5.3.7 Human papillomavirus (HPV)          

                                5.3.8 Methicillin-resistant Staphylococcus aureus (MRSA)            

                                5.3.9 Others      

                                5.3.10 Y-o-Y Growth Analysis, By Application      

                                5.3.11  Market Attractiveness Analysis, By Application   

                                5.3.12  Market Share Analysis, By Application     

                5.4 End User                      

                                5.4.1 Introduction           

                                5.4.2 Hospitals  Laboratories       

                                5.4.3 Physician office Labs           

                                5.4.4  Academics              

                                5.4.5 Others      

                                5.4.6 Y-o-Y Growth Analysis, By End User             

                                5.4.7  Market Attractiveness Analysis, By End User          

                                5.4.8  Market Share Analysis, By End User            

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Product

                                                6.1.3.3 By Technique

                                                6.1.3.4 By Application

                                                6.1.3.5 By End User

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Product

                                                6.1.4.3 By Technique

                                                6.1.4.4 By Application

                                                6.1.4.5 By End User

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Product

                                                6.1.5.3 By Technique

                                                6.1.5.4 By Application

                                                6.1.5.5 By End User

                6.2 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.3 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy            

                                6.2.6 France       

                6.4 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan         

                                6.3.5 Australia   

                                6.3.6 South Korea           

                6.5 Latin America                             

                                6.4.1 Introduction           

                                6.4.2 Brazil          

                                6.4.3 Argentina

                                6.4.4 Mexico     

                                6.4.5 Rest of Latin America          

                6.6 Middle East & Africa               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa         

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Abbott Laboratories               

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 bioMérieux SA                          

                8.3 Hologic Inc.                 

                8.4 Danaher Corporation                             

                8.5 Sbecton                       

                8.6 Dickinson and Company                        

                8.7 Cepheid Inc.                               

                8.8 Thermo Fisher Scientific Inc.               

                8.9 Roche Diagnostics                    

                8.10 Alere Inc.                  

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economic and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Infectious Diseases Diagnostics Market, By Region, From 2021 to 2026 (USD Million)
  2. Global Infectious Diseases Diagnostics Market, By Product, From 2021 to 2026 (USD Million)
  3. Global Instruments Market, By Region, From 2021 to 2026 (USD Million)
  4. Global Reagents Market, By Region, From 2021 to 2026 (USD Million)
  5. Global Services Market, By Region, From 2021 to 2026 (USD Million)
  6. Global Software Market, By Region, From 2021 to 2026 (USD Million)
  7. Global Infectious Diseases Diagnostics Market, By Application, From 2021 to 2026 (USD Million)
  8. Global Hepatitis B Market, By Region, From 2021 to 2026 (USD Million)
  9. Global Hepatitis C Market, By Region, From 2021 to 2026 (USD Million)
  10. Global Human Immunodeficiency Virus (HIV) Market, By Region, From 2021 to 2026 (USD Million)
  11. Global Tuberculosis (TB) Market, By Region, From 2021 to 2026 (USD Million)
  12. Global Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG) Market, By Region, From 2021 to 2026 (USD Million)
  13. Global human papillomavirus (HPV) Market, By Region, From 2021 to 2026 (USD Million)
  14. Global Methicillin-resistant Staphylococcus aureus (MRSA) Market, By Region, From 2021 to 2026 (USD Million)
  15. Global Infectious Diseases Diagnostics Market, By Technology, From 2021 to 2026 (USD Million)
  16. Global PCR Market, By Region, From 2021 to 2026 (USD Million)
  17. Global INAAT Market, By Region, From 2021 to 2026 (USD Million)
  18. Global DNA Sequencing Market, By Region, From 2021 to 2026 (USD Million)
  19. Global Hybridization Market, By Region, From 2021 to 2026 (USD Million)
  20. Global Infectious Diseases Diagnostics Market, By End User, From 2021 to 2026 (USD Million)
  21. Global Laboratories Market, By Region, From 2021 to 2026 (USD Million)
  22. Global Hospital Market, By Region, From 2021 to 2026 (USD Million)
  23. North America Infectious Diseases Diagnostics Market, By Product, From 2021 to 2026 (USD Million)
  24. North America Instruments Market, By Region, From 2021 to 2026 (USD Million)
  25. North America Reagents Market, By Region, From 2021 to 2026 (USD Million)
  26. North America Services Market, By Region, From 2021 to 2026 (USD Million)
  27. North America Software Market, By Region, From 2021 to 2026 (USD Million)
  28. North America Infectious Diseases Diagnostics Market, By Application, From 2021 to 2026 (USD Million)
  29. North America Hepatitis B Market, By Region, From 2021 to 2026 (USD Million)
  30. North America Hepatitis C Market, By Region, From 2021 to 2026 (USD Million)
  31. North America Human Immunodeficiency Virus (HIV) Market, By Region, From 2021 to 2026 (USD Million)
  32. North America Tuberculosis (TB) Market, By Region, From 2021 to 2026 (USD Million)
  33. North America Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG) Market, By Region, From 2021 to 2026 (USD Million)
  34. North America human papillomavirus (HPV) Market, By Region, From 2021 to 2026 (USD Million)
  35. North America Methicillin-resistant Staphylococcus aureus (MRSA) Market, By Region, From 2021 to 2026 (USD Million)
  36. North America Infectious Diseases Diagnostics Market, By Technology, From 2021 to 2026 (USD Million)
  37. North America PCR Market, By Region, From 2021 to 2026 (USD Million)
  38. North America INAAT Market, By Region, From 2021 to 2026 (USD Million)
  39. North America DNA Sequencing Market, By Region, From 2021 to 2026 (USD Million)
  40. North America Hybridization Market, By Region, From 2021 to 2026 (USD Million)
  41. North America Infectious Diseases Diagnostics Market, By End User, From 2021 to 2026 (USD Million)
  42. North America Laboratories Market, By Region, From 2021 to 2026 (USD Million)
  43. North America Hospital Market, By Region, From 2021 to 2026 (USD Million)
  44. United States Infectious Diseases Diagnostics Market, By Product, From 2021 to 2026 (USD Million)
  45. United States Infectious Diseases Diagnostics Market, By Application, From 2021 to 2026 (USD Million)
  46. United States Infectious Diseases Diagnostics Market, By Technology, From 2021 to 2026 (USD Million)
  47. United States Infectious Diseases Diagnostics Market, By End User, From 2021 to 2026 (USD Million)
  48. Canada Infectious Diseases Diagnostics Market, By Product, From 2021 to 2026 (USD Million)
  49. Canada Infectious Diseases Diagnostics Market, By Application, From 2021 to 2026 (USD Million)
  50. Canada Infectious Diseases Diagnostics Market, By Technology, From 2021 to 2026 (USD Million)
  51. Canada Infectious Diseases Diagnostics Market, By End User, From 2021 to 2026 (USD Million)
  52. Europe Infectious Diseases Diagnostics Market, By Product, From 2021 to 2026 (USD Million)
  53. Europe Instruments Market, By Region, From 2021 to 2026 (USD Million)
  54. Europe Reagents Market, By Region, From 2021 to 2026 (USD Million)
  55. Europe Services Market, By Region, From 2021 to 2026 (USD Million)
  56. Europe Software Market, By Region, From 2021 to 2026 (USD Million)
  57. Europe Infectious Diseases Diagnostics Market, By Application, From 2021 to 2026 (USD Million)
  58. Europe Hepatitis B Market, By Region, From 2021 to 2026 (USD Million)
  59. Europe Hepatitis C Market, By Region, From 2021 to 2026 (USD Million)
  60. Europe Human Immunodeficiency Virus (HIV) Market, By Region, From 2021 to 2026 (USD Million)
  61. Europe Tuberculosis (TB) Market, By Region, From 2021 to 2026 (USD Million)
  62. Europe Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG) Market, By Region, From 2021 to 2026 (USD Million)
  63. Europe human papillomavirus (HPV) Market, By Region, From 2021 to 2026 (USD Million)
  64. Europe Methicillin-resistant Staphylococcus aureus (MRSA) Market, By Region, From 2021 to 2026 (USD Million)
  65. Europe Infectious Diseases Diagnostics Market, By Technology, From 2021 to 2026 (USD Million)
  66. Europe PCR Market, By Region, From 2021 to 2026 (USD Million)
  67. Europe INAAT Market, By Region, From 2021 to 2026 (USD Million)
  68. Europe DNA Sequencing Market, By Region, From 2021 to 2026 (USD Million)
  69. Europe Hybridization Market, By Region, From 2021 to 2026 (USD Million)
  70. Europe Infectious Diseases Diagnostics Market, By End User, From 2021 to 2026 (USD Million)
  71. Europe Laboratories Market, By Region, From 2021 to 2026 (USD Million)
  72. Europe Hospital Market, By Region, From 2021 to 2026 (USD Million)
  73. U.K. Infectious Diseases Diagnostics Market, By Product, From 2021 to 2026 (USD Million)
  74. U.K. Infectious Diseases Diagnostics Market, By Application, From 2021 to 2026 (USD Million)
  75. U.K. Infectious Diseases Diagnostics Market, By Technology, From 2021 to 2026 (USD Million)
  76. U.K. Infectious Diseases Diagnostics Market, By End User, From 2021 to 2026 (USD Million)
  77. Germany Infectious Diseases Diagnostics Market, By Product, From 2021 to 2026 (USD Million)
  78. Germany Infectious Diseases Diagnostics Market, By Application, From 2021 to 2026 (USD Million)
  79. Germany Infectious Diseases Diagnostics Market, By Technology, From 2021 to 2026 (USD Million)
  80. Germany Infectious Diseases Diagnostics Market, By End User, From 2021 to 2026 (USD Million)
  81. France Infectious Diseases Diagnostics Market, By Product, From 2021 to 2026 (USD Million)
  82. France Infectious Diseases Diagnostics Market, By Application, From 2021 to 2026 (USD Million)
  83. France Infectious Diseases Diagnostics Market, By Technology, From 2021 to 2026 (USD Million)
  84. France Infectious Diseases Diagnostics Market, By End User, From 2021 to 2026 (USD Million)
  85. Italy Infectious Diseases Diagnostics Market, By Product, From 2021 to 2026 (USD Million)
  86. Italy Infectious Diseases Diagnostics Market, By Application, From 2021 to 2026 (USD Million)
  87. Italy Infectious Diseases Diagnostics Market, By Technology, From 2021 to 2026 (USD Million)
  88. Italy Infectious Diseases Diagnostics Market, By End User, From 2021 to 2026 (USD Million)
  89. Spain Infectious Diseases Diagnostics Market, By Product, From 2021 to 2026 (USD Million)
  90. Spain Infectious Diseases Diagnostics Market, By Application, From 2021 to 2026 (USD Million)
  91. Spain Infectious Diseases Diagnostics Market, By Technology, From 2021 to 2026 (USD Million)
  92. Spain Infectious Diseases Diagnostics Market, By End User, From 2021 to 2026 (USD Million)
  93. Asia Pacific Infectious Diseases Diagnostics Market, By Product, From 2021 to 2026 (USD Million)
  94. Asia Pacific Instruments Market, By Region, From 2021 to 2026 (USD Million)
  95. Asia Pacific Reagents Market, By Region, From 2021 to 2026 (USD Million)
  96. Asia Pacific Services Market, By Region, From 2021 to 2026 (USD Million)
  97. Asia Pacific Software Market, By Region, From 2021 to 2026 (USD Million)
  98. Asia Pacific Infectious Diseases Diagnostics Market, By Application, From 2021 to 2026 (USD Million)
  99. Asia Pacific Hepatitis B Market, By Region, From 2021 to 2026 (USD Million)
  100. Asia Pacific Hepatitis C Market, By Region, From 2021 to 2026 (USD Million)
  101. Asia Pacific Human Immunodeficiency Virus (HIV) Market, By Region, From 2021 to 2026 (USD Million)
  102. Asia Pacific Tuberculosis (TB) Market, By Region, From 2021 to 2026 (USD Million)
  103. Asia Pacific Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG) Market, By Region, From 2021 to 2026 (USD Million)
  104. Asia Pacific human papillomavirus (HPV) Market, By Region, From 2021 to 2026 (USD Million)
  105. Asia Pacific Methicillin-resistant Staphylococcus aureus (MRSA) Market, By Region, From 2021 to 2026 (USD Million)
  106. Asia Pacific Infectious Diseases Diagnostics Market, By Technology, From 2021 to 2026 (USD Million)
  107. Asia Pacific PCR Market, By Region, From 2021 to 2026 (USD Million)
  108. Asia Pacific INAAT Market, By Region, From 2021 to 2026 (USD Million)
  109. Asia Pacific DNA Sequencing Market, By Region, From 2021 to 2026 (USD Million)
  110. Asia Pacific Hybridization Market, By Region, From 2021 to 2026 (USD Million)
  111. Asia Pacific Infectious Diseases Diagnostics Market, By End User, From 2021 to 2026 (USD Million)
  112. Asia Pacific Laboratories Market, By Region, From 2021 to 2026 (USD Million)
  113. Asia Pacific Hospital Market, By Region, From 2021 to 2026 (USD Million)
  114. Japan Infectious Diseases Diagnostics Market, By Product, From 2021 to 2026 (USD Million)
  115. Japan Infectious Diseases Diagnostics Market, By Application, From 2021 to 2026 (USD Million)
  116. Japan Infectious Diseases Diagnostics Market, By Technology, From 2021 to 2026 (USD Million)
  117. Japan Infectious Diseases Diagnostics Market, By End User, From 2021 to 2026 (USD Million)
  118. China Infectious Diseases Diagnostics Market, By Product, From 2021 to 2026 (USD Million)
  119. China Infectious Diseases Diagnostics Market, By Application, From 2021 to 2026 (USD Million)
  120. China Infectious Diseases Diagnostics Market, By Technology, From 2021 to 2026 (USD Million)
  121. China Infectious Diseases Diagnostics Market, By End User, From 2021 to 2026 (USD Million)
  122. India Infectious Diseases Diagnostics Market, By Product, From 2021 to 2026 (USD Million)
  123. India Infectious Diseases Diagnostics Market, By Application, From 2021 to 2026 (USD Million)
  124. India Infectious Diseases Diagnostics Market, By Technology, From 2021 to 2026 (USD Million)
  125. India Infectious Diseases Diagnostics Market, By End User, From 2021 to 2026 (USD Million)
  126. Australia Infectious Diseases Diagnostics Market, By Product, From 2021 to 2026 (USD Million)
  127. Australia Infectious Diseases Diagnostics Market, By Application, From 2021 to 2026 (USD Million)
  128. Australia Infectious Diseases Diagnostics Market, By Technology, From 2021 to 2026 (USD Million)
  129. Australia Infectious Diseases Diagnostics Market, By End User, From 2021 to 2026 (USD Million)
  130. South Korea Infectious Diseases Diagnostics Market, By Product, From 2021 to 2026 (USD Million)
  131. South Korea Infectious Diseases Diagnostics Market, By Application, From 2021 to 2026 (USD Million)
  132. South Korea Infectious Diseases Diagnostics Market, By Technology, From 2021 to 2026 (USD Million)
  133. South Korea Infectious Diseases Diagnostics Market, By End User, From 2021 to 2026 (USD Million)
  134. Latin America Infectious Diseases Diagnostics Market, By Product, From 2021 to 2026 (USD Million)
  135. Latin America Instruments Market, By Region, From 2021 to 2026 (USD Million)
  136. Latin America Reagents Market, By Region, From 2021 to 2026 (USD Million)
  137. Latin America Services Market, By Region, From 2021 to 2026 (USD Million)
  138. Latin America Software Market, By Region, From 2021 to 2026 (USD Million)
  139. Latin America Infectious Diseases Diagnostics Market, By Application, From 2021 to 2026 (USD Million)
  140. Latin America Hepatitis B Market, By Region, From 2021 to 2026 (USD Million)
  141. Latin America Hepatitis C Market, By Region, From 2021 to 2026 (USD Million)
  142. Latin America Human Immunodeficiency Virus (HIV) Market, By Region, From 2021 to 2026 (USD Million)
  143. Latin America Tuberculosis (TB) Market, By Region, From 2021 to 2026 (USD Million)
  144. Latin America Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG) Market, By Region, From 2021 to 2026 (USD Million)
  145. Latin America human papillomavirus (HPV) Market, By Region, From 2021 to 2026 (USD Million)
  146. Latin America Methicillin-resistant Staphylococcus aureus (MRSA) Market, By Region, From 2021 to 2026 (USD Million)
  147. Latin America Infectious Diseases Diagnostics Market, By Technology, From 2021 to 2026 (USD Million)
  148. Latin America PCR Market, By Region, From 2021 to 2026 (USD Million)
  149. Latin America INAAT Market, By Region, From 2021 to 2026 (USD Million)
  150. Latin America DNA Sequencing Market, By Region, From 2021 to 2026 (USD Million)
  151. Latin America Hybridization Market, By Region, From 2021 to 2026 (USD Million)
  152. Latin America Infectious Diseases Diagnostics Market, By End User, From 2021 to 2026 (USD Million)
  153. Latin America Laboratories Market, By Region, From 2021 to 2026 (USD Million)
  154. Latin America Hospital Market, By Region, From 2021 to 2026 (USD Million)
  155. Brazil Infectious Diseases Diagnostics Market, By Product, From 2021 to 2026 (USD Million)
  156. Brazil Infectious Diseases Diagnostics Market, By Application, From 2021 to 2026 (USD Million)
  157. Brazil Infectious Diseases Diagnostics Market, By Technology, From 2021 to 2026 (USD Million)
  158. Brazil Infectious Diseases Diagnostics Market, By End User, From 2021 to 2026 (USD Million)
  159. Argentina Infectious Diseases Diagnostics Market, By Product, From 2021 to 2026 (USD Million)
  160. Argentina Infectious Diseases Diagnostics Market, By Application, From 2021 to 2026 (USD Million)
  161. Argentina Infectious Diseases Diagnostics Market, By Technology, From 2021 to 2026 (USD Million)
  162. Argentina Infectious Diseases Diagnostics Market, By End User, From 2021 to 2026 (USD Million)
  163. Mexico Infectious Diseases Diagnostics Market, By Product, From 2021 to 2026 (USD Million)
  164. Mexico Infectious Diseases Diagnostics Market, By Application, From 2021 to 2026 (USD Million)
  165. Mexico Infectious Diseases Diagnostics Market, By Technology, From 2021 to 2026 (USD Million)
  166. Mexico Infectious Diseases Diagnostics Market, By End User, From 2021 to 2026 (USD Million)
  167. Rest of Latin America Infectious Diseases Diagnostics Market, By Product, From 2021 to 2026 (USD Million)
  168. Rest of Latin America Infectious Diseases Diagnostics Market, By Application, From 2021 to 2026 (USD Million)
  169. Rest of Latin America Infectious Diseases Diagnostics Market, By Technology, From 2021 to 2026 (USD Million)
  170. Rest of Latin America Infectious Diseases Diagnostics Market, By End User, From 2021 to 2026 (USD Million)
  171. Middle East and Africa Infectious Diseases Diagnostics Market, By Product, From 2021 to 2026 (USD Million)
  172. Middle East and Africa Instruments Market, By Region, From 2021 to 2026 (USD Million)
  173. Middle East and Africa Reagents Market, By Region, From 2021 to 2026 (USD Million)
  174. Middle East and Africa Services Market, By Region, From 2021 to 2026 (USD Million)
  175. Middle East and Africa Software Market, By Region, From 2021 to 2026 (USD Million)
  176. Middle East and Africa Infectious Diseases Diagnostics Market, By Application, From 2021 to 2026 (USD Million)
  177. Middle East and Africa Hepatitis B Market, By Region, From 2021 to 2026 (USD Million)
  178. Middle East and Africa Hepatitis C Market, By Region, From 2021 to 2026 (USD Million)
  179. Middle East and Africa Human Immunodeficiency Virus (HIV) Market, By Region, From 2021 to 2026 (USD Million)
  180. Middle East and Africa Tuberculosis (TB) Market, By Region, From 2021 to 2026 (USD Million)
  181. Middle East and Africa Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG) Market, By Region, From 2021 to 2026 (USD Million)
  182. Middle East and Africa human papillomavirus (HPV) Market, By Region, From 2021 to 2026 (USD Million)
  183. Middle East and Africa Methicillin-resistant Staphylococcus aureus (MRSA) Market, By Region, From 2021 to 2026 (USD Million)
  184. Middle East and Africa Infectious Diseases Diagnostics Market, By Technology, From 2021 to 2026 (USD Million)
  185. Middle East and Africa PCR Market, By Region, From 2021 to 2026 (USD Million)
  186. Middle East and Africa INAAT Market, By Region, From 2021 to 2026 (USD Million)
  187. Middle East and Africa DNA Sequencing Market, By Region, From 2021 to 2026 (USD Million)
  188. Middle East and Africa Hybridization Market, By Region, From 2021 to 2026 (USD Million)
  189. Middle East and Africa Infectious Diseases Diagnostics Market, By End User, From 2021 to 2026 (USD Million)
  190. Middle East and Africa Laboratories Market, By Region, From 2021 to 2026 (USD Million)
  191. Middle East and Africa Hospital Market, By Region, From 2021 to 2026 (USD Million)
  192. Middle East Infectious Diseases Diagnostics Market, By Product, From 2021 to 2026 (USD Million)
  193. Middle East Infectious Diseases Diagnostics Market, By Application, From 2021 to 2026 (USD Million)
  194. Middle East Infectious Diseases Diagnostics Market, By Technology, From 2021 to 2026 (USD Million)
  195. Middle East Infectious Diseases Diagnostics Market, By End User, From 2021 to 2026 (USD Million)
  196. Africa Infectious Diseases Diagnostics Market, By Product, From 2021 to 2026 (USD Million)
  197. Africa Infectious Diseases Diagnostics Market, By Application, From 2021 to 2026 (USD Million)
  198. Africa Infectious Diseases Diagnostics Market, By Technology, From 2021 to 2026 (USD Million)
  199. Africa Infectious Diseases Diagnostics Market, By End User, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample